Software Engineer, GPS Knowledge Systems at Bristol-Myers Squibb

New Brunswick, New Jersey, United States

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries

Requirements

  • 1+ years of experience in Information Technology, data analytics, or related industries (highly desired)
  • 1+ year experience working on information model relevant workflows and/or tools: semantic model development, data ontologies, application of graph databases (significant differentiator)
  • Hands-on experience with SDLC methodologies, including DevOps, Agile, and Waterfall, ideally in regulated environments (preferred)
  • Experience with programming languages relevant to managing data and information models (e.g., Python, Java, Scala)
  • Proficiency with modern analytics tools and technologies, potentially including GitHub, SQL, R, dbt, Domino, Tableau, etc
  • Experience designing, implementing, and managing graph models and, ideally, applications related to information modeling or interest in learning (desired)
  • Experience with cloud environments and services, preferably AWS
  • Experience with graph platforms (e.g., Neo4j, Amazon Neptune), including model design and querying (preferred)
  • Demonstrated ability to conceptualize, design, and refine ontologies to accurately model domain knowledge, entities, relationships, and rules for organizational data (preferred)
  • Experience with DevOps principles for CI/CD pipelines
  • Experience deploying AI models (highly desirable)
  • Experience with systems using the Model Context Protocol (MCP) to interact with AI models (highly desirable)
  • Hands-on experience with agile methodologies and tools such as JIRA
  • Experience with ELT and data engineering processes

Responsibilities

  • Help implement infrastructure around information models, leveraging emerging technologies to deliver business value
  • Ensure adherence to SDLC and analytics best practices (scalability, version control, documentation, deployment)
  • Partner with stakeholders to capture business needs
  • Translate complex concepts for various stakeholders and be willing and able to implement those solutions using a robust SDLC process

Skills

Software Design
Data Modeling
Semantic Models
Knowledge Management
AI
Analytics
Data Principles

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI